Tyrosine Kinase-Inhibitors effective in epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer (NSCL)

被引：0
|
作者：
Pommer, Peter
机构：
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2016年 / 141卷 / 18期
关键词：
D O I：
10.1055/s-0042-110629
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1284 / 1284
页数：1
相关论文
共 50 条
  • [41] Study on the therapeutic effect of epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer patients
    Chen, Fei
    Li, Hongbo
    Zhang, Huanming
    MINERVA GASTROENTEROLOGY, 2024, 70 (01): : 135 - 137
  • [42] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treatment of Metastatic Non-Small Cell Lung Cancer, with a Focus on Afatinib
    Morin-Ben Abdallah, Sami
    Hirsh, Vera
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [43] PRESCRIBING TRENDS ACROSS EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS IN NON-SMALL CELL LUNG CANCER IN IRELAND
    Gorry, C.
    Connolly, E.
    Trela-Larsen, L.
    Barry, M.
    VALUE IN HEALTH, 2019, 22 : S491 - S491
  • [44] TREATMENT OF LEPTOMENINGEAL METASTASIS FROM NON-SMALL CELL LUNG CANCER WITH EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS
    Nanjo, S.
    Katakami, N.
    Otsuka, K.
    Tachikawa, R.
    Hata, A.
    Otsuka, K.
    Kaji, R.
    Fujita, S.
    Hayashi, M.
    Tomii, K.
    ANNALS OF ONCOLOGY, 2010, 21 : 142 - 142
  • [45] Epidermal growth factor receptor inhibitors in non-small cell lung cancer
    Dancey, Janet E.
    DRUGS, 2007, 67 (08) : 1125 - 1138
  • [46] Feasibility of Rebiopsy in Non-Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
    Hasegawa, Takaaki
    Sawa, Toshiyuki
    Futamura, Yohei
    Horiba, Akane
    Ishiguro, Takashi
    Marui, Tsutomu
    Yoshida, Tsutomu
    INTERNAL MEDICINE, 2015, 54 (16) : 1977 - 1980
  • [47] Rebiopsy for Patients with Non-Small Cell Lung Cancer after Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Failure
    Li, Xuefei
    Su, Chunxia
    Ren, Shengxiang
    Zhao, Chao
    Jiang, Tao
    Zhou, Caicun
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1256 - S1256
  • [48] Epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer: a decade of progress and hopeful future
    Rajagopalan, Kumar
    Govindan, Ramaswamy
    JOURNAL OF THORACIC DISEASE, 2015, 7 (03) : 217 - 219
  • [49] Primary and Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer: An Update
    Ayoola, Ayodele
    Barochia, Amit
    Belani, Kiran
    Belani, Chandra P.
    CANCER INVESTIGATION, 2012, 30 (05) : 433 - 446
  • [50] Third-generation epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer
    Wright, Natalie M. Andrews
    Goss, Glenwood D.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 : S247 - S264
12345